Link among apolipoprotein E E4, gait, and cognition in neurodegenerative diseases: ONDRI study
Alzheimer's & Dementia · 2024-04 · 20 (4) · 2968-2979
DOI: 10.1002/alz.13740 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 12.03.2024. Verfasst von Ryota Sakurai und 26 weiteren Autor:innen. Beteiligte Einrichtung: Research Team for Social Participation and Healthy Aging, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Itabashi-ku, Tokyo, Japan. Hauptthemen laut MEDLINE: Apolipoprotein E4, Neurodegenerative Diseases. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ontario government, Baycrest Foundation, Bruyere Research Institute.
Abstract (Originalsprache)
INTRODUCTION Apolipoprotein E E4 allele ( APOE E4) and slow gait are independently associated with cognitive impairment and dementia. However, it is unknown whether their coexistence is associated with poorer cognitive performance and its underlying mechanism in neurodegenerative diseases. METHODS Gait speed, APOE E4, cognition, and neuroimaging were assessed in 480 older adults with neurodegeneration. Participants were grouped by APOE E4 presence and slow gait. Mediation analyses were conducted to determine if brain structures could explain the link between these factors and cognitive performance. RESULTS APOE E4 carriers with slow gait had the lowest global cognitive performance and smaller gray matter volumes compared to non‐ APOE E4 carriers with normal gait. Coexistence of APOE E4 and slow gait best predicted global and domain‐specific poorer cognitive performances, mediated by smaller gray matter volume. DISCUSSION Gait slowness in APOE E4 carriers with neurodegenerative diseases may indicate extensive gray matter changes associated with poor cognition. Highlights APOE E4 and slow gait are risk factors for cognitive decline in neurodegenerative diseases. Slow gait and smaller gray matter volumes are associated, independently of APOE E4. Worse cognition in APOE E4 carriers with slow gait is explained by smaller GM volume. Gait slowness in APOE E4 carriers indicates poorer cognition‐related brain changes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Team for Social Participation and Healthy Aging, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Itabashi-ku, Tokyo, Japan.
- Gait & Brain Lab, St. Joseph' Health Care London, Lawson Health Research, Western University, Division of Geriatric Medicine, London, Ontario, Canada.
- Department of Medicine, Division of Geriatric Medicine, Parkwood Hospital, Western University, Parkwood Institute, London, Ontario, Canada.
- Neuroscience, Mobility and Balance Lab, Department of Kinesiology and Health Sciences, University of Waterloo, Waterloo, Ontario, Canada.
- Rotman Research Institute, Baycrest Health Sciences, Toronto, Ontario, Canada.
- Data Science and Advanced Analytics, St. Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada.
ORCID-Profile: Ryota Sakurai, Frederico Pieruccini-Faria, Benjamin Cornish, Malcolm A Binns, Derek Beaton, Allison Ann Dilliott, Donna Kwan, Joel Ramirez, Brian Tan, Kelly M Sunderland, Carmela Tartaglia, Elizabeth Finger, Lorne Zinman, Morris Freedman, Paula M McLaughlin, Richard H Swartz, Sean Symons, Anthony E Lang, Robert Bartha, Sandra E Black, Mario Masellis, Robert A Hegele, William McIlroy, Manuel Montero-Odasso
Förderung
- Ontario government
- Baycrest Foundation
- Bruyere Research Institute
- Centre for Addiction and Mental Health Foundation
- London Health Sciences Foundation
- McMaster University Faculty of Health Sciences
- Ottawa Brain and Mind Research Institute
- Queen's University Faculty of Health Sciences
Zitieren
APA
Sakurai, R., Pieruccini-Faria, F., Cornish, B., Fraser, J., Binns, M. A., Beaton, D., Dilliott, A. A., Kwan, D., Ramirez, J., Tan, B., Scott, C. J. M., Sunderland, K. M., Tartaglia, C., Finger, E., Zinman, L., Freedman, M., McLaughlin, P. M., Swartz, R. H., Symons, S., …, & Montero-Odasso, M. (2024). Link among apolipoprotein E E4, gait, and cognition in neurodegenerative diseases: ONDRI study. Alzheimer's & Dementia, 20(4), 2968-2979. https://doi.org/10.1002/alz.13740
Vancouver
Sakurai R, Pieruccini-Faria F, Cornish B, Fraser J, Binns MA, Beaton D, et al. Link among apolipoprotein E E4, gait, and cognition in neurodegenerative diseases: ONDRI study. Alzheimer's & Dementia. 2024;20(4):2968-2979. doi:10.1002/alz.13740
BibTeX
@article{Sakurai2024,
author = {Sakurai, Ryota and Pieruccini-Faria, Frederico and Cornish, Benjamin and Fraser, Julia and Binns, Malcolm A and Beaton, Derek and Dilliott, Allison Ann and Kwan, Donna and Ramirez, Joel and Tan, Brian and Scott, Christopher J M and Sunderland, Kelly M and Tartaglia, Carmela and Finger, Elizabeth and Zinman, Lorne and Freedman, Morris and McLaughlin, Paula M and Swartz, Richard H and Symons, Sean and Lang, Anthony E and Bartha, Robert and Black, Sandra E and Masellis, Mario and Hegele, Robert A and McIlroy, William and ONDRI Investigators, ONDRI Investigators and Montero-Odasso, Manuel},
title = {Link among apolipoprotein E E4, gait, and cognition in neurodegenerative diseases: ONDRI study},
journal = {Alzheimer's & Dementia},
year = {2024},
volume = {20},
number = {4},
pages = {2968--2979},
doi = {10.1002/alz.13740}
}
EUVIMED